Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Computed tomography assessment of lung structure in patients undergoing cardiac surgery with cardiopulmonary bypass.

Rodrigues RR, Sawada AY, Rouby JJ, Fukuda MJ, Neves FH, Carmona MJ, Pelosi P, Auler JO, Malbouisson LM.

Braz J Med Biol Res. 2011 Jun;44(6):598-605. Epub 2011 Apr 20.

2.

Postcardiopulmonary bypass hypoxemia: a prospective study on incidence, risk factors, and clinical significance.

Weiss YG, Merin G, Koganov E, Ribo A, Oppenheim-Eden A, Medalion B, Peruanski M, Reider E, Bar-Ziv J, Hanson WC, Pizov R.

J Cardiothorac Vasc Anesth. 2000 Oct;14(5):506-13.

PMID:
11052429
3.

Transvascular transport of 67Ga in the lungs after cardiopulmonary bypass surgery.

Raijmakers PG, Groeneveld AB, Schneider AJ, Teule GJ, van Lingen A, Eijsman L, Thijs LG.

Chest. 1993 Dec;104(6):1825-32.

PMID:
8252972
4.

Atelectasis is a major cause of hypoxemia and shunt after cardiopulmonary bypass: an experimental study.

Magnusson L, Zemgulis V, Wicky S, Tydén H, Thelin S, Hedenstierna G.

Anesthesiology. 1997 Nov;87(5):1153-63.

PMID:
9366468
5.

Off-pump versus on-pump coronary artery bypass surgery and postoperative pulmonary dysfunction.

Montes FR, Maldonado JD, Paez S, Ariza F.

J Cardiothorac Vasc Anesth. 2004 Dec;18(6):698-703.

PMID:
15650976
6.

Matrix Metalloproteinase-9 Production following Cardiopulmonary Bypass Was Not Associated with Pulmonary Dysfunction after Cardiac Surgery.

Lin TC, Lin FY, Lin YW, Hsu CH, Huang GS, Wu ZF, Tsai YT, Lin CY, Li CY, Tsai CS.

Mediators Inflamm. 2015;2015:341740. doi: 10.1155/2015/341740. Epub 2015 Jul 27.

7.

Arterial hyperoxia during cardiopulmonary bypass and postoperative cognitive dysfunction.

Fontes MT, McDonagh DL, Phillips-Bute B, Welsby IJ, Podgoreanu MV, Fontes ML, Stafford-Smith M, Newman MF, Mathew JP; Neurologic Outcome Research Group (NORG) of the Duke Heart Center.

J Cardiothorac Vasc Anesth. 2014 Jun;28(3):462-6. doi: 10.1053/j.jvca.2013.03.034. Epub 2013 Aug 22.

8.

Changes in cysteinyl leukotrienes during and after cardiac surgery with cardiopulmonary bypass in patients with and without chronic obstructive pulmonary disease.

de Prost N, El-Karak C, Avila M, Ichinose F, Vidal Melo MF.

J Thorac Cardiovasc Surg. 2011 Jun;141(6):1496-502.e3. doi: 10.1016/j.jtcvs.2011.01.035. Epub 2011 Mar 5.

9.

Ventilation-perfusion inequality in patients undergoing cardiac surgery.

Hachenberg T, Tenling A, Nyström SO, Tyden H, Hedenstierna G.

Anesthesiology. 1994 Mar;80(3):509-19.

PMID:
8141447
10.

The influence of cardiopulmonary bypass on respiratory dysfunction in early postoperative period.

Andrejaitiene J, Sirvinskas E, Bolys R.

Medicina (Kaunas). 2004;40 Suppl 1:7-12.

11.
12.

Effect of CPAP during cardiopulmonary bypass on postoperative lung function. An experimental study.

Magnusson L, Zemgulis V, Wicky S, Tydén H, Hedenstierna G.

Acta Anaesthesiol Scand. 1998 Nov;42(10):1133-8.

PMID:
9834793
13.

Hyperbaric oxygen preconditioning improves myocardial function, reduces length of intensive care stay, and limits complications post coronary artery bypass graft surgery.

Yogaratnam JZ, Laden G, Guvendik L, Cowen M, Cale A, Griffin S.

Cardiovasc Revasc Med. 2010 Jan-Mar;11(1):8-19. doi: 10.1016/j.carrev.2009.03.004.

PMID:
20129356
14.

Effects of alveolar recruitment on arterial oxygenation in patients after cardiac surgery: a prospective, randomized, controlled clinical trial.

Minkovich L, Djaiani G, Katznelson R, Day F, Fedorko L, Tan J, Carroll J, Cheng D, Karski J.

J Cardiothorac Vasc Anesth. 2007 Jun;21(3):375-8. Epub 2006 Apr 21.

PMID:
17544889
15.

Renal dysfunction after cardiac surgery with normothermic cardiopulmonary bypass: incidence, risk factors, and effect on clinical outcome.

Provenchère S, Plantefève G, Hufnagel G, Vicaut E, De Vaumas C, Lecharny JB, Depoix JP, Vrtovsnik F, Desmonts JM, Philip I.

Anesth Analg. 2003 May;96(5):1258-64, table of contents.

PMID:
12707117
16.

The influence of selective pulmonary perfusion on the inflammatory response and clinical outcome of patients with chronic obstructive pulmonary disease undergoing cardiopulmonary bypass.

Kiessling AH, Guo FW, Gökdemir Y, Thudt M, Reyher C, Scherer M, Beiras-Fernandez A, Moritz A.

Interact Cardiovasc Thorac Surg. 2014 Jun;18(6):732-9. doi: 10.1093/icvts/ivu062. Epub 2014 Mar 14.

PMID:
24632426
17.

Cardiopulmonary bypass transiently inhibits intraventricular vortex ring formation in patients undergoing coronary artery bypass graft surgery.

Pagel PS, Gandhi SD, Iqbal Z, Hudetz JA.

J Cardiothorac Vasc Anesth. 2012 Jun;26(3):376-80. doi: 10.1053/j.jvca.2011.10.011. Epub 2011 Dec 23.

PMID:
22196924
18.

Risk factors for pulmonary complications following cardiac surgery with cardiopulmonary bypass.

Ji Q, Mei Y, Wang X, Feng J, Cai J, Ding W.

Int J Med Sci. 2013 Sep 10;10(11):1578-83. doi: 10.7150/ijms.6904. eCollection 2013.

19.

[The influence of cardiopulmonary bypass on respiratory function in an early postoperative period].

Sirvinskas E, Andrejaitiene J, Bluzas J, Raliene L, Siudikas A.

Ter Arkh. 2006;78(3):44-51. Russian.

PMID:
17019958
20.

[Protective effect of Shenmai injection on lung injury induced by cardiac pulmonary bypass].

Chen FF, Lin LN, Miao JX.

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2009 May;29(5):414-7. Chinese.

PMID:
19673331

Supplemental Content

Support Center